Brief: Catalyst Pharmaceuticals Q3 Revenue USD 148.4 Million Vs. IBES Estimate USD 136.8 Million
Nov 05 (Reuters) - Catalyst Pharmaceuticals Q3 adjusted net income USD 86.1 million. Q3 net income USD 52.8 million Q3 operating income USD 66.3 million outlook FY revenue USD 565-585 million